Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature

Surgical Case Reports

Table 1 Esophageal carcinosarcoma treated with preoperative therapy

First author	Year	Age	Sex	Stage	Preoperative therapy	Clinical response	Pathological response	Prognosis
Zuiki [23]	2009	50	Male	II	CRT (FP+62 Gy)	PR	ND	36 months alive
Zuiki [23]	2009	66	Male	I	CRT (FP+40.2 Gy)	PR	ND	19 months alive
Kobayashi [24]	2010	68	Male	III	CRT (S-1/CDDP+40 Gy)	PR	npCR	60 months alive
Kobayashi [24]	2010	64	Male	III	CRT (FP+38 Gy)	SD	npCR	11 months dead
Kuo [7]	2010	68	Male	III	CRT (ND)	ND	ND	27 months alive
Kuo [7]	2010	45	Male	IV	CRT (ND)	ND	ND	6 months alive
Kobayashi [25]	2015	69	Male	II	FP	SD	NC	60 months alive
Present case	2016	73	Male	III	DCF	SD	npCR	12 months alive

CRT chemoradiotherapy, PR partial response, npCR near pathological complete response, SD stable disease, FP 5-fluorouracil and cisplatin, S-1/CDDP S-1 and cisplatin, NC no change, DCF docetaxel, cisplatin, and 5-fluorouracil, ND not described